The HFSA Virtual AHFTC Board Certification Review 2022 will be comprised of renowned heart failure experts presenting curriculum that has been tailored to the actual ABIM AHFTC examination blueprint. The educational content is rigorous, up-to-date, scientifically fair, and balanced, and meets the needs of heart failure providers who care for patients with heart failure. The course will take place over three (3) days (August 12-14, 2022) - see full agenda here.
The program will be made up of the following components to allow attendees greater access to the content.
This pre-recorded, OnDemand webinar series features the basics and can be completed at the attendee's convenience.
A three-day virtual meeting (August 12-14, 2022) delivered by top experts in the field. Sessions will be available to download within 48 hours of the session date.
Post-meeting, Q&A panel taking place at the HFSA Annual Scientific Meeting 2022 on Saturday, October 1, 2022 at 11:35 AM - 12:35 PM ET to allow attendees to ask follow-up questions. More information coming soon!
Receive access to a robust Question Bank that adheres to the ABIM AHFTC blueprint and question format.
Registrants receive a comprehensive reading list, which contains additional references regarding guideline-directed and evidence-based therapy
The HFSA Virtual AHFTC Board Certification Review 2022 is designed for physicians who are preparing to take the ABIM Advanced Heart Failure and Transplant Cardiology Certification Examination or the Maintenance of Certification Assessment Examination, or heart failure specialists seeking an in-depth review in heart failure.
Upon completion of the activity, participants will demonstrate improved competence and ability to:
For the Certification Examination in Advanced Heart Failure and Transplant Cardiology:
- Identify gaps in knowledge about advanced heart failure and transplant cardiology
- Focus study efforts on filling identified knowledge gaps
- Practice for the certification examination with ABIM-style multiple-choice test questions
For Clinical Practice:
- Describe the epidemiology of heart failure, including environmental factors, and implement strategies for the prevention of heart failure
- Describe the pathophysiology of heart failure, including normal physiology and compensatory and maladaptive mechanisms
- Assess and follow the patient with acute or advanced heart failure, using non-invasive and invasive tests and biomarkers
- Implement guideline-based therapy for patients with chronic heart failure, including pharmacologic agents; non-pharmacologic options, such as diet and exercise; and implantable devices
- Implement appropriate care strategies for patients undergoing chemotherapy or with pulmonary hypertension, heart failure with preserved ejection fraction, or cardiorenal syndrome
- Manage comorbidities in patients with chronic heart failure, including sleep disordered breathing, anemia, and depression
- Implement strategies for effective disease management of the patient with advanced heart failure, including palliative care and transition to outpatient care
- Provide peri-operative management of heart failure patients undergoing cardiac transplantation or implantation of a mechanical circulatory device
Concise presentations by national experts will focus on blueprint content
Each webinar is 30 minutes in length. This series is available to all registered attendees in the online meeting platform under the OnDemand tab to be completed at the attendee's convenience.
|Heart Failure Epidemiology and Risk Factors||Sadiya Khan, MD, MSc|
|Pathophysiology I: Cellular and Energetic Considerations||Daniel Burkhoff, MD, PhD|
|Pathophysiology II: Hemodynamic, Structural, and Neurohormonal Considerations||Daniel Burkhoff, MD, PhD|
|Diagnosis and Clinical Assessment||Mark Drazner, MD, MSc, FHFSA|
|Cardio-Oncology for the HF Boards||Bonnie Ky, MD, MSCE, FACC|
|Clinico-Pathologic Correlates in HF / Images for the HF Boards||Jon Lomasney, MD|
|Statistics for the HF Board||Brian Claggett, PhD|
|Hemodynamics in HF I||James C. Fang, MD, FHFSA|
|Pulmonary Hypertension - Classification and Initial Evaluation||Jonathan Rich, MD, FHFSA|
|Diabetes and COPD||
Maria Rosa Costanzo, MD, FHFSA
|RV Failure and TR Management||Barry A. Borlaug, MD|
The virtual meeting dates will take place August 12-14, 2022. Attendees should anticipate being online for the full sessions to maximize their learning potential. To attend a session on a virtual meeting day, click on the “Sessions” tab in the online platform.
If a participant is unable to participate live, the OnDemand recordings of the sessions will be available within 48 hours of the session date on the “OnDemand” tab of the online platform. Participants will also have access to the HFSA Virtual AHFTC Board Certification Review 2022 enduring program for one-year in the HFSA Learning Center.
See the full agenda here, and look below for the basic outline on days and topics.
|Day #1 | Friday, August 12||3;00 PM - 6:30 PM ET||
|Day #2 | Saturday, August 13||11:00 AM - 8:00 PM ET||
|Day #3 | Sunday, August 14||11:00 AM - 5:30 PM ET||
Learners will have the opportunity to ask last-minute questions with the course chairs prior to the examination. More information coming soon.
In addition to the core program components, attendees will have access to the following:
- 2022 HFSA Question Bank, an updated questions bank adhering to the ABIM AHFTC blueprint and question format
- 2022 HFSA Comprehensive Reading List, list containing additional references regarding guideline and evidence-based therapy
- HFSA Virtual AHFTC Board Certification Review 2022, one-year access to the enduring program in the HFSA Learning Center
- PDF copies of the presentation slides
- Live polling, Q&A, and chat features available during the livestream days
- Chat with fellow attendees and faculty throughout the course of the meeting